Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Enhances Sleep Quality and Recovery: Enjoy deeper, more restorative sleep
So far, clinical trials havent resulted in regulatory approval, and pharmaceutical companies havent been motivated to invest in further development
WADA Prohibition The World Anti-Doping Agency classification for these peptides: GLP3 likely classified under prohibited substances as a GLP-1 receptor agonist Cagrilintide status as amylin analog may fall under peptide hormone prohibitions Combined formulation would be prohibited under multiple substance categories No Therapeutic Use Exemptions (TUEs) available for either component Detection methods under development for anti-doping testing WADAs position reflects that these remain investigational agents without regulatory approval from health authorities worldwide
Wang and Xu, 2017
US$ 24.18
US$ 24.43
US$ 24.92
US$ 28.43
US$ 21.56
US$ 21.27
